Johnson & Johnson Total Liabilities 2010-2024 | JNJ

Johnson & Johnson total liabilities for the quarter ending September 30, 2024 were $108.129B, a 14.02% increase year-over-year.

  • Johnson & Johnson total liabilities for 2023 were $98.784B, a 10.66% decline from 2022.
  • Johnson & Johnson total liabilities for 2022 were $110.574B, a 2.39% increase from 2021.
  • Johnson & Johnson total liabilities for 2021 were $107.995B, a 3.24% decline from 2020.

Johnson & Johnson Total Liabilities 2010-2024 | JNJ

  • Johnson & Johnson total liabilities for 2023 were $98.784B, a 10.66% decline from 2022.
  • Johnson & Johnson total liabilities for 2022 were $110.574B, a 2.39% increase from 2021.
  • Johnson & Johnson total liabilities for 2021 were $107.995B, a 3.24% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B